教員業績データベース |
|
言語種別 | 英語 |
演題 | Hepatocellular carcinoma development in Japanese patients with HCV genotype 1 infection who achieved sustained virologic response by ledipasvir/sofosbuvir and protease inhibitor with peginterferon plus ribavirin. |
学会名 | The 68th Annual Meeting of the American Association for the Study of Liver Diseases |
主催者 | American Association for the Study of Liver Diseases |
学会区分 | 国際学会 |
発表形態 | ポスター掲示 |
発表形式名 | Poster sessions |
発表者・共同発表者 | Korenaga Masaaki, Izumi Namiki, Yokosuka Osamu, Takehara Tetsuo, Sakamoto Naoya, Nishiguchi Shuhei, Ikeda Fusao, Yanase Mikio, Toyoda Hidenori, Genda Takuya, Umemura Takeji, Yatsuhashi Hiroshi, Ide Tatsuya, Toda Nobuo, Nirei Kazushige, Ueno Yoshiyuki, Nishigaki Yoichi, Nakane Kunio, Kanto Tatsuya, Omata Masao, Mizokami Masashi. |
発表年月日 | 2017/10/21 |
開催地 (都市, 国名) |
Washington DC |
学会抄録 | Hepatology 66(suppl1),563A 2017 |